InvestSMART

Alterity Therapeutics Limited (ASX: ATH) - Announcements

Current share price for ATH : $0.380 0.03 (7.32%)+

ASX company news and announcements for Alterity Therapeutics Limited (ATH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Alterity Therapeutics Limited (ATH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Alterity Therapeutics Limited (ATH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Alterity Therapeutics Limited (ATH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$87 Meeting with US FDA provides development path for ATH434 30 Jun 2020 10:34AM $0.015 $0.380 risen by 2,433.33%
$87 Change in substantial holding 9 Jun 2020 8:13AM $0.017 $0.380 risen by 2,135.29%
$87 Change in substantial holding 28 May 2020 8:18AM $0.018 $0.380 risen by 2,011.11%
$87 Change in substantial holding (BMYMC) 27 May 2020 9:42AM $0.020 $0.380 risen by 1,800%
$87 Change in substantial holding 27 May 2020 8:19AM $0.020 $0.380 risen by 1,800%
$87 Appendix 2A and Section 708A(5) Cleansing Notice 25 May 2020 4:50PM $0.020 $0.380 risen by 1,800%
$87 Proposed issue of Securities - ATH 22 May 2020 6:42PM $0.020 $0.380 risen by 1,800%
$87 Presentation on ATH434 to American Academy of Neurology 21 May 2020 8:21AM $0.020 $0.380 risen by 1,800%
$87 Appendix 4C and Quarterly Update 30 Apr 2020 2:42PM $0.019 $0.380 risen by 1,900%
$87 NASDAQ Temporary Relief 22 Apr 2020 9:59AM $0.017 $0.380 risen by 2,135.29%
$87 Appendix 2A and Section 708A(5) Cleansing 27 Mar 2020 8:55AM $0.017 $0.380 risen by 2,135.29%
$87 Proposed issue of Securities - ATH 26 Mar 2020 8:45AM $0.018 $0.380 risen by 2,011.11%
$87 Form 6K 28 Feb 2020 8:36AM $0.017 $0.380 risen by 2,135.29%
$87 Half Yearly Report and Accounts 27 Feb 2020 5:36PM $0.017 $0.380 risen by 2,135.29%
$87 NASDAQ Non-Compliance Notice Received 7 Feb 2020 2:40PM $0.020 $0.380 risen by 1,800%
$87 Appendix 4C - quarterly 31 Jan 2020 3:11PM $0.020 $0.380 risen by 1,800%
$87 Appendix 3B an 708A notice 17 Jan 2020 2:03PM $0.020 $0.380 risen by 1,800%
$87 Alterity receives a $4.8 million R&D Tax Incentive Refund 15 Jan 2020 9:22AM $0.021 $0.380 risen by 1,709.52%
$87 European Orphan Designation granted for PBT434 for MSA 14 Jan 2020 12:23PM $0.019 $0.380 risen by 1,900%
$87 Upcoming Release of warrants from Voluntary Escrow 11 Dec 2019 9:55AM $0.023 $0.380 risen by 1,552.17%
$87 AGM Results of Meeting 26 Nov 2019 11:24AM $0.025 $0.380 risen by 1,420%
$87 AGM Presentation 2019 26 Nov 2019 9:38AM $0.025 $0.380 risen by 1,420%
$87 Chairman's Address to Shareholders 26 Nov 2019 9:35AM $0.025 $0.380 risen by 1,420%
$87 Appendix 3B 21 Nov 2019 5:35PM $0.026 $0.380 risen by 1,361.54%
$87 Alterity AGM Investor Conference Call 20 Nov 2019 11:25AM $0.025 $0.380 risen by 1,420%

526 - 550 of 575 results

Page 22 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.